Lecture 14: Thrombotic disorders Flashcards

1
Q

Describe virchows triad for arterial and venous thrombosis:

A

Triad:
- Stasis FLOW of blood
- Vascular injury BLOOD VESSELS
- Hypercoagulability COMPONENTS of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can cause vascular injury?

A
  • Trauma
  • Surgical manipulation
  • Prior thrombosis
  • Atherosclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes stasis?

A

Stasis (mainly venous thrombosis)
- Immobility
-> Post op state, debility, coma

Pressure
- Catheter, tumor obstruction

Increase viscosity
- Polycythemia
- Dehydration
- EPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes blood hypercoagulability?

A
  • Increased procoagulants
  • Decrease in inhibitors
  • Impaired fibrinolysis (Rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What generally creates a deep vein thrombosis?

A

Fibrin + RBC primarily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the signs and symptoms of DVT?

A

Nonspecific and common

  • Leg swelling
  • Leg pain
  • Oedema

-> Pain, tenderness, swelling

Notoriously hard to diagnose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the signs and symptoms of PE?

A

PE:
- SOB
- Chest pain
- Tachycardia
- Tachypnoea

Malignancy common cause.

Again non-specific and common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the algorithm for DVT diagnosis:

A

Clinical score + D-dimer to determine if ultrascan sound needed.

High clinical score goes straight to US scan.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is D-dimer?

A
  • Breakdown product of fibrin
  • Positive in most DVT and PE cases
  • BUT can also be positive in patients with inflam and surgery, therefore, should be considered with clinical score.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the classic symptom triad of PE?

A

classic symptom triad of:
- Pleuritic pain
- SOB
- Heamoptysis (Rare, comes from lung infections, peripheral issues, doesnt change treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Write some notes on thrombophilia:

A
  • Tendency to develop thrombosis.
  • Acquired, inherited, or both i.e anti-phospholipid
  • Manifested as VTE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the causes of VTE?

A

~30-40% spontaneous

  • ~50% of these have hereditary factor which increases risk: Thrombophilia

Remainder provoked events
- Surgery or trauma
- Immobility
- Hospitlisation
- Malignancy
- Pregnancy etc etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the types of inherited thrombophilia:

A
  • Abnormal factor function (i.e protein C - Factor V leiden, most common hereditary cause of thrombophilia)
  • Deficiency of inhibitors (i.e Antithrombin, protein C or S)
  • Increased factor levels i.e prothrombin, factor 8
  • Dysfibrinogenemia (Very rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the function of factor 5?

A
  • Factor 5a enhances factor 10 activation.
  • Activated protein C cleaves normal factor 5a.
  • Slows 10a production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens in factor 5 leiden?

A
  • Activated protein C unable to cleave factor V leiden
  • Factor Xa activation continues
  • Va levels ~20% higher
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why test for APCr?

A

Heterozygotes 3-7 fold increase risk for thrombosis

Homozygotes carry a 50-100 fold increase risk of thrombosis

17
Q

Whats the value in testing for thrombophilia?

A
  • Initial VTE risk increased
  • BUT recurrence not increased
  • Limited use for families
  • Testing now reserved for young patients particularly spontaneous VTE
  • NO role in arterial thrombosis
18
Q

What are the treatments for PE and DVT?

A

Anticoagulation

Initially -> Heparin
= Immediate effect
Requires antithrombin: Inactivation of Xa and 2a (thrombin)

Heparin is an inhibitor through increased antithrombin effect, APTT 1+1 is prolonged, TCT markedly prolonged, reversed with protamine.

Antithrombin deficiency does not increase APTT 1+1…

19
Q

What is the treatment following Heparin?

A
  • LMWH
    -> Warfarin at the same time, minimum five days of overlap

Alternatively, now a direct oral agent preferred i.e dabigatran , inhibits coagulation, allows fibrinolytic mechanisms to operate unhindered by further clotting

20
Q

How does warfarin act?

A

Inhibits functional activation of Vit-K dependent factors i.e 2,7,9,10

Inhibits recycling of Vit K factors.

21
Q

What are some considerations of warfarin use?

A
  • Needs monitoring (INR) (Prothrombin ratio)
  • Risks of interactions with many drugs
    -> Antibiotics, anticonvulsants to name a few
  • High INR increases bleeding risk further (INR 2-3 is therapeutic range)
  • Takes time to reduce vit K availability to reduce production of active clotting factors
  • Usually 5-7 days to a therapeutic level
22
Q

How do you reverse warfarin?

A
  • Vit K IV

If immediate reversal required:
- Prothrombinex
- Factors 2,9,10

23
Q

What are some direct acting oral anticoagulants? and how do they act?

A
  • Oral direct inhibitors of activated clotting factors
  • Rivaroxaban (10a) and dabigatran (thrombin) are both the same as warfarin for the treatment of VTE

(Probs sup to warfarin for anticoagulation in atrial fibrillation - better stroke prevention with similar rates of bleeding

24
Q

What are the advantages and disadvantages of DOACs?

A

Advantages
- No monitoring needed, fixed dose
- Less intracranial heamorrhage (Compared to warfarin)

Disadvantages
- Renal excretion (especially dabigatran) retained with renal impairment

25
Q

How do DOACs impact clotting tests?

A

Dabigatran: TCT extremely sensitive; APTT prolonged at therapeutic levels (1+1 prolonged), PR prolonged if very high.

Rivaroxaban: PR prolonged to some extent, APTT less so.

Specific assay available for both.

A normal APTT and PR does not exclude some effect of these medicines….

26
Q

How are DOAC reversed?

A

Antidote for dabigatran: Idarucizumab

-> AB that binds to dabigatran very tightly (does not bind clotting factors)
-> Immediate reversal - very effective

27
Q

Whats the morbidity of DVT and PE?

A

Up to 30% of DVT patients develop post thrombotic syndrome
-> Pain, swelling/oedema, redness, venous eczma, ulceration
-> Graduated compression stockings may help

2% of PE patients may develop chronic thromboembolic pulmonary hypertension
- SOBOE, dizziness, fatigue